BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 9, 2025
Home » Authors » Sharon Kingman

Articles by Sharon Kingman

Study Could Lead to Inhibitors for Multidrug Molecular Pump

May 1, 2013
By Sharon Kingman
LONDON – A more detailed understanding of the workings of the membrane-bound pump that many bacteria use to eject antibiotics will, researchers hope, lead to ways of making bacteria once again susceptible to antibiotics that currently fail to kill them.
Read More

Genes Involved with T Cells May Cause Rare Liver Disease

April 24, 2013
By Sharon Kingman
LONDON – A huge international study has established that a rare liver disease, which often occurs simultaneously with inflammatory bowel disease, is, in fact, a separate disease.
Read More

Finnish Study Shows Cell Metabolism Is Key to Cancer

April 18, 2013
By Sharon Kingman
LONDON – A new study has connected known differences in the metabolism typical of cancer cells to the pathway leading to apoptosis, or cell death. Researchers working in Finland have, for the first time, linked metabolic changes in cancer cells to the mechanism that, in normal cells, prevents abnormal cellular proliferation.
Read More

Finnish Study Shows Cell Metabolism Is Key to Cancer

April 17, 2013
By Sharon Kingman
A new study has connected known differences in the metabolism typical of cancer cells to the pathway leading to apoptosis, or cell death. Researchers working in Finland have, for the first time, linked metabolic changes in cancer cells to the mechanism that, in normal cells, prevents abnormal cellular proliferation. The discovery is likely to encourage drug developers to consider whether existing drugs that modify cellular metabolism could be used in the future to treat cancer.
Read More

Mouse Study Puts Blindness Genes into the Spotlight

April 10, 2013
By Sharon Kingman
LONDON – Scientists are close to identifying new genes that may be linked to several eye diseases in humans, many of which cause blindness. The researchers are being guided by genes they have found in mice that, when absent, cause similar defects to those occurring in the eyes of humans who are affected by conditions such as one type of age-related macular degeneration (AMD).
Read More

Chance Observation Triggers Idea to Treat Polycystic Kidneys

April 3, 2013
By Sharon Kingman
A fault in glucose metabolism lies at the heart of polycystic kidney disease, a common inherited condition that can cause end-stage renal failure by the age of 50, new research has shown.
Read More

Immune Modulation Could Speed Bone Fracture Healing

March 27, 2013
By Sharon Kingman
LONDON – The part of the immune system that deals with viruses and other pathogens can also delay the healing of bone fractures, a new study has found.
Read More

Anticancer Drugs May Hold Key to Parasite Treatment

March 20, 2013
By Sharon Kingman
LONDON – The genome of the tapeworm has been sequenced, providing researchers with a panoply of genes that may provide new targets for treatment of those parasites. Scientists hope that, by identifying tapeworm genes that are similar to human genes, it may be possible to select candidate drugs that are already approved for use against other conditions, such as cancer.
Read More

Newly Identified Enzyme Could Rival PARPs as a Drug Target

March 13, 2013
By Sharon Kingman
LONDON – Study of a family affected by an inherited neurological disease has helped to reveal the identity of an enzyme that could point the way to new therapies for cancer and cardiovascular disease.
Read More

Drive to Inhibit 'Master Switch' for Tumor Embryonic Growth

Feb. 27, 2013
By Sharon Kingman
LONDON – Identification of a protein that orchestrates many of the changes that permit a normal cell to turn into a cancer cell will open up an entirely new field of cancer therapeutics, the researchers who made the discovery predicted.
Read More
Previous 1 2 … 6 7 8 9 10 11 12 13 14 … 107 108 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 9, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 9, 2025.
  • US flag, stock market chart, White House

    100 days of uncertainty

    BioWorld
    The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
  • AI generated, 3D rendering of protein degradation

    AACR 2025: Induced proximity strategy, beyond degraders

    BioWorld
    Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
  • Deal handshake with coin, chart background

    Shionogi to acquire Japan Tobacco pharma companies for $1.1B

    BioWorld
    Shionogi & Co. said it plans to acquire Japan Tobacco Inc. (JT) subsidiaries Torii Pharmaceutical Co. and Akros Pharma Inc. for ¥160 billion (US$1.1 billion) to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing